Scribe Integration Platform Approved for Canada Software

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Scribe Integration Platform Approved for Canada Software Licensing Supply Arrangement

OTTAWA, ON--(Marketwired - Oct 21, 2015) - Scribe Software , a global data integration leader, today announced the approval of Scribe Insight for Canada's Software Licensing Supply Arrangement (SLSA) . Under the SLSA terms, Canada's federal government agencies can now purchase the integration platform through Scribe's strategic partner, A Hundred Answers , at a pre-negotiated price without going through a competitive bid process.

"The addition of Scribe Insight to the SLSA is the catalyst government agencies have been waiting for," noted Chuck Emond, principal at A Hundred Answers. "The Canadian federal government is standardizing on Microsoft Dynamics CRM as its new case management system, but until now, integration challenges posed a major roadblock to adoption. With instant, cost-effective access to Scribe, government agencies can easily integrate Dynamics CRM with all existing applications, unlocking the full value of the case management system."

Scribe Insight is the only integration platform for Dynamics CRM that has passed the technical and pricing requirements needed to be included on the SLSA, the Canadian government's pre-approved software list. With this approval, Scribe will accelerate government agencies' migration and integration of legacy data into the new Shared Case Management System (SCMS) based on Dynamics CRM.

"Our addition to the SLSA marks a major milestone for Scribe, building on our long history of successful use within government agencies across the world," said Shawn McGowan , CEO, Scribe Software. "It's a reflection of the need for government agencies to improve service through better use of data, and of Scribe's ability to integrate siloed data in real time from diverse systems such as CRM and proprietary databases. We are thrilled to have been selected as the Canadian government's trusted integration platform, and look forward to working with A Hundred Answers to improve the key processes of Canada's government agencies."

Scribe Insight is a trusted integration enabler for government agencies throughout North America, including the USDA, the U.S. Department of Defense, the Illinois Department of Corrections, the Ohio Department of Developmental Disabilities, the County Commissioners Association of Pennsylvania and more. Federal, state and local government agencies rely on Scribe Insight to easily integrate data from CRM systems, such as Microsoft Dynamics CRM and Salesforce, with virtually any other application or source of critical agency data. Whether the data is on premise, in the cloud, or anywhere in between, Scribe's platform includes pre-built adapters and an easy user interface that makes integration fast and affordable.

"Integration is a critical component of deploying new systems," continued McGowan. "Canada's government agencies need a full 360-degree view of each individual they serve to successfully leverage the Shared Case Management System, and seamlessly connecting data from relevant sources is central to this view."

To learn more about the SLSA, visit: http://logiciels-software.tpsgc-pwgsc.gc.ca/a...rl-eng.cfm

For more information on Scribe Insight, visit: http://www.scribesoft.com/scribe_insight

About Scribe Software Scribe is an established global provider of solutions that easily bring data anywhere it is needed -- regardless of IT infrastructure. Scribe's award-winning products help 12,000 customers and 1,200 partners use data -- cloud-based, on-premise or a mix -- to increase revenue, provide superior service, and create business value faster. It's easy-to-use, enterprise-ready solutions are backed by extensive support options and training, and service customers across a wide array of industries including financial services, life sciences, manufacturing, and media and entertainment companies.

Follow Scribe on Twitter , Facebook , LinkedIn , YouTube , SlideShare , and Instagram .

About A Hundred Answers A Hundred Answers is a fast growing, employee-based management consulting and systems integration firm serving public and private sector clients across North America. AHA's consulting and IT professionals have subject matter expertise and specialized technical skills in Privacy and Risk Management, Business Transformation, IT Advisory, CRM, Digital Integration, and Data Dynamics. AHA services extend through the full lifecycle of client needs, from business advisory to technology enablement and managed services. This follow-through is a founding principle of AHA: the company's team not only advises, it implements. Through this discipline of being accountable for the achievement of business goals, AHA consistently deliver practical and relevant consulting services. Founded in 2002, AHA is headquartered in Ottawa, ON, serving clients across North America. Visit the company at ahundredanswers.com, follow AHA on Twitter , like them on Facebook and visit their LinkedIn page.

Contact Information: Dan MacLeod Scratch Marketing + Media for Scribe 240-603-2887 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 8

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 371

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 283

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 334

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 442

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 247

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 278

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 460

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 522

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 438

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading

Top 5 Most Recently Viewed Articles

HCW Biologics Advances T-Cell Engagers for Solid Tumors

Updated Category News Views 181

HCW Biologics Unveils Innovative Treatments for Solid Tumors HCW Biologics Inc., a clinical-stage biopharmaceutical company, recently announced important developments in its research on second-generation, multi-specific T-cell engagers. These therapies specifically target solid tumors, notably pancreatic cancer, utilizing the company's proprietary TRBC product discovery...

Continue Reading
Highlights of the Upcoming Small Cap Growth Investor Event

Updated Category News Views 56

Overview of the Small Cap Growth Virtual Investor Conference The Small Cap Growth Virtual Investor Conference is set to take place soon, bringing together a diverse group of companies and investors. This exciting virtual event will provide a platform for companies to showcase their offerings to interested investors from various backgrounds. The conference promises an...

Continue Reading
Crexi Auction Performance Highlights Investor Reengagement

Updated Category News Views 286

Introduction to Crexi Auction's 2025 Performance As the landscape of commercial real estate evolves, Crexi Auction stands out with remarkable performance metrics indicating a strong rebound in market confidence. Recent reports highlight a 96% close rate for Crexi Auction during the first half of the year, showcasing a notable 10% year-over-year increase in transaction...

Continue Reading
Digihost and NANO Nuclear Jointly Propel New York's Energy Future

Updated Category News Views 145

Digihost and NANO Nuclear Join Forces for Renewable Energy Digihost Technology Inc. and NANO Nuclear Energy Inc. have united to submit a proposal to the New York State Energy Research and Development Authority (NYSERDA). Their aim? To facilitate the development of cutting-edge, clean energy solutions that will revolutionize New York's energy landscape. This collaboration...

Continue Reading
Syndax Pharmaceuticals (NASDAQ: SNDX) Faces Market Challenges

Updated Category News Views 151

Syndax Pharmaceuticals (NASDAQ: SNDX) and Its Market Journey Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) has recently made headlines as its stock price has fallen to a 52-week low of $12.75. This decline is indicative of the current hurdles the biopharmaceutical company is facing in a challenging market landscape. Investors have noted that the stock is currently in an...

Continue Reading